Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study.
Saved in:
| Title: | Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study. |
|---|---|
| Authors: | Fautrel B; Sorbonne University, AP-HP, Hôpital de La Pitié-Salpêtrière, INSERM UMRS 1136, Paris, France., Bouhnik Y; Paris IBD Center, Groupe hospitalier privé Ambroise Paré-Hartmann, Neuilly-sur-Seine, France., Salliot C; Rheumatology Department, Centre Hospitalier Universitaire d'Orléans, Orléans, France., Carbonnel F; Hôpital Bicêtre, AP-HP, Le Kremlin Bicêtre, France., Fumery M; Département de Gastroentérologie, CHU Amiens, Amiens, France., Bernardeau C; Clinique François Chénieux, Limoges, France., Maugars Y; INSERM, UMR 1229, RMeS, Regenerative Medicine and Skeleton, Université de Nantes, ONIRIS, Nantes, France.; Odontology Department, University of Nantes, Nantes, France.; Rheumatology Department, CHU de Nantes, Nantes, France., Flamant M; Département de Gastroentérologie, Clinique Jules Verne, Nantes, France., Coury F; Rheumatology Department, Lyon Sud Hospital, Hospices Civils de Lyon, University of Lyon, Lyon, France.; INSERM UMR 1033, Lyon Immunopathology Federation, Lyon, France., Braithwaite B; Sanoïa e-Health Services, 188 av 2nd Division Blindée, 13420, Gémenos, France. bbraithwaite@sanoia.com., Hateb S; Biogen France SAS, Gastroenterology and Rhumatologie, Biosimilars, Courbevoie, France., Addison J; Biogen IDEC, Clinical Research, Biosimilars, Maidenhead, UK. |
| Corporate Authors: | PERFUSE investigators |
| Source: | Drugs - real world outcomes [Drugs Real World Outcomes] 2024 Dec; Vol. 11 (4), pp. 573-591. Date of Electronic Publication: 2024 Oct 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2199-1154 |
|---|---|
| DOI: | 10.1007/s40801-024-00459-6 |
